Physicians' Academy for Cardiovascular Education

T2DM & cardiovascular risk: Determinants of Risk and Implications for Choice of Therapy

May 6, 2017 - Beijing, China - Prof. Sanjay Rajagopalan, MD Cleveland, OH, USA - CDMC 2017

This lecture was part of a Cardio Diabetes Master Class 'CVM Summit 2017, held on May 5, 2017 in Beijing, China

Educational information

The educational objectives of the program were:

Disclosures

Prof. Sanjay Rajagopalan, MD - is Chief, Cardiovascular Medicine - Herman Hellerstein Chair of Cardiovascular Research. Director, Cardiovascular Research Institute. Professor of Medicine, Case Western Reserve School of Medicine - Cleveland, OH

Funding

The master class is supported by an unrestricted educational grant provided by Takeda Pharmaceuticals Inc

Download lecture as PDF

View slides